President Donald Trump on Monday signed a sweeping executive order setting a 30-day deadline for drugmakers to electively lower the cost of prescription drugs in the U.S. or face new limits down the road over what the government will pay. The order calls on the health department, led by Robert F. Kennedy Jr., to broker new price tags for drugs over the next month. If deals are not reached, Kennedy will be tasked with developing a new rule that ties the price the U.S. pays for medications to lower prices paid by other countries. Read more: https://www.king5.com/article/news/nation-world/pharmaceutical-industry-criticizes-trump-drug-price-plan/507-9bdfd783-4d75-4f85-aad2-8c42217e28a9